276 related articles for article (PubMed ID: 22975606)
1. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma.
Chen JZ; Le QT; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Cui NJ; Zhao C
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):929-34. PubMed ID: 22975606
[TBL] [Abstract][Full Text] [Related]
2. Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
Li M; Huang XG; Yang ZN; Lu JY; Zhan YZ; Xie WJ; Zhou DJ; Wang L; Zhu DX; Lin ZX
Br J Radiol; 2016 Sep; 89(1065):20150621. PubMed ID: 27376590
[TBL] [Abstract][Full Text] [Related]
3. The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients.
Hu W; Zhu G; Guan X; Wang X; Hu C
Radiat Oncol; 2013 Oct; 8():230. PubMed ID: 24094078
[TBL] [Abstract][Full Text] [Related]
4. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
[TBL] [Abstract][Full Text] [Related]
6. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
9. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
10. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
11. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
[TBL] [Abstract][Full Text] [Related]
12. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
14. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
Lin L; Yao JJ; Zhou GQ; Guo R; Zhang F; Zhang Y; Xu L; Zhang LL; Lin AH; Ma J; Sun Y
Oncotarget; 2016 Apr; 7(15):20680-90. PubMed ID: 26980744
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.
Tang LL; Tang XR; Li WF; Chen L; Tian L; Lin AH; Sun Y; Ma J
Oral Oncol; 2017 Jun; 69():68-73. PubMed ID: 28559023
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.
Zhang F; Cheng YK; Li WF; Guo R; Chen L; Sun Y; Mao YP; Zhou GQ; Liu X; Liu LZ; Lin AH; Tang LL; Ma J
BMC Cancer; 2015 Oct; 15():709. PubMed ID: 26472233
[TBL] [Abstract][Full Text] [Related]
18. An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.
Hung TM; Fan KH; Chen EY; Lin CY; Kang CJ; Huang SF; Liao CT; Ng SH; Wang HM; Chang JT
Medicine (Baltimore); 2017 Feb; 96(6):e6036. PubMed ID: 28178144
[TBL] [Abstract][Full Text] [Related]
19. Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Guo Q; Pan J; Zong J; Zheng W; Zhang C; Tang L; Chen B; Cui X; Xiao Y; Chen Y; Lin S
Medicine (Baltimore); 2015 May; 94(20):e808. PubMed ID: 25997052
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
Guan X; Wang X; Liu Y; Hu C; Zhu G
Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
